JTCS Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Google Scholar
Right arrow Articles by Bai, Y.
Right arrow Articles by Qin, Y.-W.
PubMed
Right arrow Articles by Bai, Y.
Right arrow Articles by Qin, Y.-W.
Related Collections
Right arrow Valve disease

J Thorac Cardiovasc Surg 2009;138:733-737
© 2009 The American Association for Thoracic Surgery

Evolving Technology/Basic Science

Percutaneous reimplantation of a pulmonary valved stent in sheep: A potential treatment for bioprosthetic valve degeneration

Yuan Bai, MDa, Gang-Jun Zong, MDc, Hai-Bing Jiang, MDa, Wei-Ping Li, MDb, Hong Wu, MDa, Xian-Xian Zhao, MDa, Yong-Wen Qin, MDa,*

a Department of Cardiology, Changhai Hospital, the Second Military Medical University, Shanghai, China
b Department of Ultrasonography, Changhai Hospital, the Second Military Medical University, Shanghai, China
c Department of Cardiology, 101 Hospital of PLA, Wuxi, Jiangsu Province, China

Received for publication February 19, 2009; revisions received April 24, 2009; accepted for publication May 18, 2009.

* Address for reprints: Yong-Wen Qin, MD, Department of Cardiology, Changhai Hospital, The Second Military Medical University, Shanghai, 200433, China. (Email: ywqinsmmu{at}yahoo.cn).

Objective: Percutaneous pulmonary valve replacement has been recently introduced into clinical practice. Patients with transcatheter pulmonary valve replacement will definitely face the problems of valve degeneration. In addition to surgical re-replacement of the degenerated bioprosthetic valves, we studied the replacement of degenerated bioprosthetic valves with transcatheter reimplantation of stent-mounted pulmonary valves.

Methods: Percutaneous pulmonary valve replacement was first performed in 6 sheep used a homemade valved stent. Two months after the initial procedure, the 6 sheep previously implanted with a valved stent underwent the same implantation procedure of a pulmonary valved stent. Hemodynamic assessment of the bioprosthetic pulmonary valve was obtained by echocardiography immediately post-implant and at 2 months follow-up.

Results: All 6 sheep had successful transcatheter stent-mounted pulmonary valve replacement in the first experiment. After 2 months, reimplantation was successful in 5 sheep but failed in 1 sheep because the first valved stent was pushed to the bifurcation of the pulmonary artery by the delivery sheath. Echocardiography confirmed the stents were in the desired position during the follow-up. The remaining 5 sheep with normal valvular and cardiac functionality survived for 3 months after implantation.

Conclusion: Transcatheter stent-mounted bioprosthetic pulmonary valve reimplantation is feasible in an animal model and more convenient than open chest reimplantation.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2009 by The American Association for Thoracic Surgery.